Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

IM Cannabis (IMCC) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to 27.9%.

  • IM Cannabis' EBITDA Margin rose 388200.0% to 27.9% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.66%, marking a year-over-year increase of 659800.0%. This contributed to the annual value of 0.01% for FY2024, which is 222200.0% up from last year.
  • Latest data reveals that IM Cannabis reported EBITDA Margin of 27.9% as of Q3 2025, which was up 388200.0% from 11.57% recorded in Q2 2025.
  • Over the past 5 years, IM Cannabis' EBITDA Margin peaked at 155.73% during Q2 2022, and registered a low of 899.17% during Q3 2022.
  • In the last 5 years, IM Cannabis' EBITDA Margin had a median value of 0.0% in 2025 and averaged 54.72%.
  • In the last 5 years, IM Cannabis' EBITDA Margin tumbled by -8402200bps in 2022 and then surged by 8834900bps in 2023.
  • Quarter analysis of 5 years shows IM Cannabis' EBITDA Margin stood at 0.09% in 2021, then plummeted by -249346bps to 234.41% in 2022, then skyrocketed by 30bps to 163.8% in 2023, then skyrocketed by 143bps to 70.68% in 2024, then tumbled by -61bps to 27.9% in 2025.
  • Its EBITDA Margin stands at 27.9% for Q3 2025, versus 11.57% for Q2 2025 and 0.0% for Q1 2025.